Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
74.95
-0.59 (-0.78%)
At close: May 22, 2026, 4:00 PM EDT
74.63
-0.32 (-0.43%)
After-hours: May 22, 2026, 7:53 PM EDT
Arrowhead Pharmaceuticals Market Cap
Arrowhead Pharmaceuticals has a market cap or net worth of $10.56 billion as of May 22, 2026. Its market cap has increased by 531.87% in one year.
Market Cap
10.56B
Enterprise Value
10.16B
1-Year Change
531.87%
Ranking
Category
Stock Price
$74.95
Market Cap Chart
Since January 15, 2004, Arrowhead Pharmaceuticals's market cap has increased from $300.00K to $10.56B, an increase of 3,518,977.91%. That is a compound annual growth rate of 59.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 10.56B | 17.09% |
| Dec 31, 2025 | 9.02B | 285.42% |
| Dec 31, 2024 | 2.34B | -28.84% |
| Dec 29, 2023 | 3.29B | -23.54% |
| Dec 30, 2022 | 4.30B | -37.84% |
| Dec 31, 2021 | 6.92B | -11.95% |
| Dec 31, 2020 | 7.86B | 29.67% |
| Dec 31, 2019 | 6.06B | 451.13% |
| Dec 31, 2018 | 1.10B | 299.42% |
| Dec 29, 2017 | 275.20M | 154.58% |
| Dec 30, 2016 | 108.10M | -70.48% |
| Dec 31, 2015 | 366.20M | -9.27% |
| Dec 31, 2014 | 403.60M | -3.88% |
| Dec 31, 2013 | 419.90M | 1,153.43% |
| Dec 31, 2012 | 33.50M | -24.04% |
| Dec 30, 2011 | 44.10M | -31.42% |
| Dec 31, 2010 | 64.30M | 93.09% |
| Dec 31, 2009 | 33.30M | -15.70% |
| Dec 31, 2008 | 39.50M | -72.93% |
| Dec 31, 2007 | 145.90M | -2.60% |
| Dec 29, 2006 | 149.80M | 25.99% |
| Dec 30, 2005 | 118.90M | 101.87% |
| Dec 31, 2004 | 58.90M | 19,533.33% |
| Jan 15, 2004 | 300.00K | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BridgeBio Pharma | 13.77B |
| Summit Therapeutics | 13.56B |
| Ionis Pharmaceuticals | 12.52B |
| Exelixis | 12.48B |
| Axsome Therapeutics | 12.02B |
| Madrigal Pharmaceuticals | 11.84B |
| Cytokinetics | 10.60B |
| BioMarin Pharmaceutical | 10.46B |